• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

BTGGF:US

11.3600 USD 0.5000 4.60%

As of 20:10:00 ET on 10/22/2014.

Snapshot for BTG PLC (BTGGF)

Open: 11.2800 Day's Range: 11.2800 - 11.3600 Volume: 18,641
Previous Close: 10.8600 52wk Range: 6.6000 - 11.5000 1-Yr Rtn: +70.31%

Stock Chart for BTGGF

No chart data available.
  • BTGGF:US 11.3600
  • 1D
  • 1M
  • 1Y
10.8600
Interactive BTGGF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BTGGF

Current P/E Ratio (ttm) -
Estimated P/E(03/2015) 46.1916
Relative P/E vs. SPX -
Earnings Per Share (GBP) (ttm) -
Est. EPS (GBP) (03/2015) 0.1530
Est. PEG Ratio -
Market Cap (M USD) 4,121.45
Shares Outstanding (M) 362.80
30 Day Average Volume 838
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/11/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BTGGF

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for BTGGF

BTG plc licenses, develops and commercializes pharmaceuticals and has a pipeline of development programs targeting neurological and other disorders, including varicose veins. The Company also has a substantial and growing revenue stream of milestone payments and royalties from out-licensed products.

Louise MakinCEO/Executive DirectorRolf SoderstromCFO/Executive Director
Peter StratfordCTO:Interventional MedicineGuenter R JanhoferChief Medical Officer/Head:Dev
More Company Profile & Key Executives for BTGGF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil